This trial has completed recruitment on this platform, and is no longer accepting new referrals.
A study to test an investigational vaccine that may protect people from getting sick if they come into contact with the SARS-CoV-2 virus, which causes COVID-19; also known as coronavirus.
Trial ID: NCT04470427
Moderna’s Commitment to Diversity & Inclusion
Moderna is committed to researching a safe and effective vaccine that protects people from all backgrounds against COVID-19.
People from racial and ethnic minority groups are at even greater risk of getting sick and dying from COVID-19. Given that certain populations can respond differently to medical therapies, it is important that study volunteers from all races and ethnicities participate in the COVE Study to ensure the vaccine is safe and effective for everyone to use.
Moderna has proudly partnered with 99 clinical research sites across the US, and we actively collaborate with nonprofits, local community organizations, and faith and cultural leaders to address current and historical barriers, build trust, and raise awareness of this important clinical trial to communities at highest risk of COVID-19.
The mRNA-1273 vaccine is being developed to prevent COVID-19, the disease resulting from Severe Acute Respiratory Syndrome coronavirus (SARS-CoV-2) infection. Study volunteers will participate and be followed by medical staff for up to two years. The study doctor and medical staff will talk to you about additional medical support that you will receive if you experience COVID-19 symptoms at any time while in this clinical trial. Insurance is not needed to join this clinical trial, and compensation for your time will be available.
Given that certain populations can respond differently to medical therapies, it is extremely important that this clinical trial include people from all races and ethnicities to ensure the vaccine is safe and effective for everyone to use.
The total length of trial participation is two years and includes seven visits to the study clinic and monthly phone calls from the study doctor.
You will need to travel to one of the 100 sites taking part in this clinical trial. Sites are located in:
Not yet Recruiting